Other factors that contributed to the reduction in the NT-proBNP levels included overweight, obesity, and ongoing treatment with cardioactive drugs, such as ACE inhibitors, spironolactone, B blockers, and diuretics. This evidence concerns the gene ACE and obesity due to melanocortin 4 receptor deficiency.